Упрощенная HTML-версия
138
93.
Ertapenem therapy for community-acquired pneumonia in the elderly / G.L.
[et al.] //
– 2003. – Vol. 51, № 11. – P. 1526-1532.
94.
Etiology and outcome of community-acquired pneumonia in patients with
diabetes mellitus / M. Falguera [et al.] // CHEST. – 2005. - Vol. 128. – P. 3233-3239.
95. Etiology and outcome of community-acquired pneumonia in relation to age
and severity in hospitalized adult patients / N.
et al.] //
– 2006. – Vol. 44, № 12. – P. 906-915.
96.
Ewig S. Community-acquired pneumonia. Epidemiology, risk, and prognosis /
S. Ewig // Eur. Respir. Mon. – 1997. – Vol. 3. – P. 13-35.
97. Ewig S. Assessment of pneumonia severity: a European perspective / S. Ewig,
A. Torres, M. Woodhead // Eur. Respir. J. – 2006. - № 27. – P. 6-8.
98.
Farr B.M. Predicting death in patients hospitalized for community-acquired
pneumonia / B.M. Farr, A.J. Sloman, M.J. Fisch // Ann. Intern. Med. – 1991. - №
115. – P. 428-436.
99.
Fein A.M. The approach to nonresolving pneumonia in the elderly / A.M. Fein,
S.H. Feinsilver // Semin. Respir. Infect. – 1993. - № 8. – P. 59-72.
100.
Fernandez- Sabe W. Community-acquired pneumonia in very elderly
patients: causative organisms, clinical characteristics, and outcomes / W. Fernandez-
Sabe, J. Carratala, B. Roson [et al.] // Medicine (Baltimore). – 2003. - № 82 (3). – P.
159-169.
101.
Fine M.J. A prediction rule to identify low-risk patients with
community-acquired pneumonia / M.J. Fine, T.E. Auble, D.M. Yealy [et al.] // N.
Engl. J. Med. – 1997. - № 336. – P. 243-250.
102.
Fine M.J. Prognosis and outcome of patients with community-acquired
pneumonia: a meta-analysis / M.J. Fine, M.A. Smith, C.A. Carson [et al.] // JAMA. –
1996. – Vol. 275. – P. 134-141.
103.
Grimble R.F. Inflammatory response in the elderly / R.F. Grimble //
Curr. Opin. Clin. Nutr. Metab. Care. – 2003. – Vol. 6, № 1. – P. 21-29.